Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,509 | 6,275 | 33,152 | 23,337 | 115,553 |
| Depreciation Amortization | -5,789 | -230 | 4,490 | 3,043 | -207 |
| Income taxes - deferred | -1,286 | 1,130 | 6,745 | 6,189 | -87,767 |
| Accounts receivable | -707 | -1,089 | -2,469 | -3,767 | 2,342 |
| Accounts payable and accrued liabilities | -10,984 | 11,793 | 3,040 | 3,759 | 3,508 |
| Other Working Capital | -747 | 6,074 | 2,737 | 4,317 | 3,125 |
| Other Operating Activity | 29,805 | 8,031 | 16,519 | 14,897 | 9,393 |
| Operating Cash Flow | $12,801 | $31,984 | $64,214 | $51,775 | $45,947 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -101,048 | -679 | -552 | -1,795 | -1,019 |
| Purchase Of Investment | -512,606 | -349,258 | -420,461 | -346,622 | -394,517 |
| Sale Of Investment | 601,598 | 399,862 | 344,317 | 306,918 | 327,227 |
| Investing Cash Flow | $-12,056 | $49,925 | $-76,696 | $-41,499 | $-68,309 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 734 | 3,550 | 5,634 | 6,264 |
| Financing Cash Flow | $0 | $734 | $3,550 | $5,634 | $6,264 |
| Exchange Rate Effect | 47 | 265 | -91 | 53 | -1 |
| Beginning Cash Position | 135,498 | 52,590 | 61,613 | 45,650 | 61,749 |
| End Cash Position | 136,290 | 135,498 | 52,590 | 61,613 | 45,650 |
| Net Cash Flow | $792 | $82,908 | $-9,023 | $15,963 | $-16,099 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,801 | 31,984 | 64,214 | 51,775 | 45,947 |
| Capital Expenditure | -101,048 | -679 | -552 | -1,795 | -1,019 |
| Free Cash Flow | -88,247 | 31,305 | 63,662 | 49,980 | 44,928 |